0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
MicroRNA (miRNA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-27H1668
Home | Market Reports | Science| Biological Sciences
Global MicroRNA miRNA Market Insights and Forecast to 2028
BUY CHAPTERS

MicroRNA (miRNA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-27H1668
Report
September 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

MicroRNA (miRNA) - Market Size

The global market for MicroRNA (miRNA) was estimated to be worth US$ 183.8 million in 2023 and is forecast to a readjusted size of US$ 382.1 million by 2030 with a CAGR of 10.5% during the forecast period 2024-2030

MicroRNA (miRNA) - Market

MicroRNA (miRNA) - Market

North American market for MicroRNA (miRNA) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for MicroRNA (miRNA) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for MicroRNA (miRNA) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of MicroRNA (miRNA) include Thermofisher Scientific (Life Technologies), Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc. and New England Biolabs, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for MicroRNA (miRNA), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of MicroRNA (miRNA) by region & country, by Type, and by Application.
The MicroRNA (miRNA) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MicroRNA (miRNA).
Market Segmentation

Scope of MicroRNA (miRNA) - Market Report

Report Metric Details
Report Name MicroRNA (miRNA) - Market
Forecasted market size in 2030 US$ 382.1 million
CAGR 10.5%
Forecasted years 2024 - 2030
Segment by Type:
  • Sample collection
  • miRNA cDNA Synthesis
  • Profiling & Purification
  • Detection
  • Functional Studies
Segment by Application
  • Cancer
  • Infectious Diseases
  • Immunological Disorder
  • Cardiovascular Disease
  • Neurological Disease
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermofisher Scientific (Life Technologies), Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs, Quantabio, BioGenex, SeqMatic LLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of MicroRNA (miRNA) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of MicroRNA (miRNA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of MicroRNA (miRNA) in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the MicroRNA (miRNA) - Market size in 2030?

Ans: The MicroRNA (miRNA) - Market size in 2030 will be US$ 382.1 million.

Who are the main players in the MicroRNA (miRNA) - Market report?

Ans: The main players in the MicroRNA (miRNA) - Market are Thermofisher Scientific (Life Technologies), Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs, Quantabio, BioGenex, SeqMatic LLC

What are the Application segmentation covered in the MicroRNA (miRNA) - Market report?

Ans: The Applications covered in the MicroRNA (miRNA) - Market report are Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others

What are the Type segmentation covered in the MicroRNA (miRNA) - Market report?

Ans: The Types covered in the MicroRNA (miRNA) - Market report are Sample collection, miRNA cDNA Synthesis, Profiling & Purification, Detection, Functional Studies

1 Market Overview
1.1 MicroRNA (miRNA) Product Introduction
1.2 Global MicroRNA (miRNA) Market Size Forecast
1.3 MicroRNA (miRNA) Market Trends & Drivers
1.3.1 MicroRNA (miRNA) Industry Trends
1.3.2 MicroRNA (miRNA) Market Drivers & Opportunity
1.3.3 MicroRNA (miRNA) Market Challenges
1.3.4 MicroRNA (miRNA) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global MicroRNA (miRNA) Players Revenue Ranking (2023)
2.2 Global MicroRNA (miRNA) Revenue by Company (2019-2024)
2.3 Key Companies MicroRNA (miRNA) Manufacturing Base Distribution and Headquarters
2.4 Key Companies MicroRNA (miRNA) Product Offered
2.5 Key Companies Time to Begin Mass Production of MicroRNA (miRNA)
2.6 MicroRNA (miRNA) Market Competitive Analysis
2.6.1 MicroRNA (miRNA) Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by MicroRNA (miRNA) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MicroRNA (miRNA) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sample collection
3.1.2 miRNA cDNA Synthesis
3.1.3 Profiling & Purification
3.1.4 Detection
3.1.5 Functional Studies
3.2 Global MicroRNA (miRNA) Sales Value by Type
3.2.1 Global MicroRNA (miRNA) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global MicroRNA (miRNA) Sales Value, by Type (2019-2030)
3.2.3 Global MicroRNA (miRNA) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cancer
4.1.2 Infectious Diseases
4.1.3 Immunological Disorder
4.1.4 Cardiovascular Disease
4.1.5 Neurological Disease
4.1.6 Others
4.2 Global MicroRNA (miRNA) Sales Value by Application
4.2.1 Global MicroRNA (miRNA) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global MicroRNA (miRNA) Sales Value, by Application (2019-2030)
4.2.3 Global MicroRNA (miRNA) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global MicroRNA (miRNA) Sales Value by Region
5.1.1 Global MicroRNA (miRNA) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global MicroRNA (miRNA) Sales Value by Region (2019-2024)
5.1.3 Global MicroRNA (miRNA) Sales Value by Region (2025-2030)
5.1.4 Global MicroRNA (miRNA) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America MicroRNA (miRNA) Sales Value, 2019-2030
5.2.2 North America MicroRNA (miRNA) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe MicroRNA (miRNA) Sales Value, 2019-2030
5.3.2 Europe MicroRNA (miRNA) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific MicroRNA (miRNA) Sales Value, 2019-2030
5.4.2 Asia Pacific MicroRNA (miRNA) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America MicroRNA (miRNA) Sales Value, 2019-2030
5.5.2 South America MicroRNA (miRNA) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa MicroRNA (miRNA) Sales Value, 2019-2030
5.6.2 Middle East & Africa MicroRNA (miRNA) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions MicroRNA (miRNA) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions MicroRNA (miRNA) Sales Value
6.3 United States
6.3.1 United States MicroRNA (miRNA) Sales Value, 2019-2030
6.3.2 United States MicroRNA (miRNA) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States MicroRNA (miRNA) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe MicroRNA (miRNA) Sales Value, 2019-2030
6.4.2 Europe MicroRNA (miRNA) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe MicroRNA (miRNA) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China MicroRNA (miRNA) Sales Value, 2019-2030
6.5.2 China MicroRNA (miRNA) Sales Value by Type (%), 2023 VS 2030
6.5.3 China MicroRNA (miRNA) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan MicroRNA (miRNA) Sales Value, 2019-2030
6.6.2 Japan MicroRNA (miRNA) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan MicroRNA (miRNA) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea MicroRNA (miRNA) Sales Value, 2019-2030
6.7.2 South Korea MicroRNA (miRNA) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea MicroRNA (miRNA) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia MicroRNA (miRNA) Sales Value, 2019-2030
6.8.2 Southeast Asia MicroRNA (miRNA) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia MicroRNA (miRNA) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India MicroRNA (miRNA) Sales Value, 2019-2030
6.9.2 India MicroRNA (miRNA) Sales Value by Type (%), 2023 VS 2030
6.9.3 India MicroRNA (miRNA) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermofisher Scientific (Life Technologies)
7.1.1 Thermofisher Scientific (Life Technologies) Profile
7.1.2 Thermofisher Scientific (Life Technologies) Main Business
7.1.3 Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Products, Services and Solutions
7.1.4 Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Revenue (US$ Million) & (2019-2024)
7.1.5 Thermofisher Scientific (Life Technologies) Recent Developments
7.2 Agilent Technologies
7.2.1 Agilent Technologies Profile
7.2.2 Agilent Technologies Main Business
7.2.3 Agilent Technologies MicroRNA (miRNA) Products, Services and Solutions
7.2.4 Agilent Technologies MicroRNA (miRNA) Revenue (US$ Million) & (2019-2024)
7.2.5 Agilent Technologies Recent Developments
7.3 Merck KGaA
7.3.1 Merck KGaA Profile
7.3.2 Merck KGaA Main Business
7.3.3 Merck KGaA MicroRNA (miRNA) Products, Services and Solutions
7.3.4 Merck KGaA MicroRNA (miRNA) Revenue (US$ Million) & (2019-2024)
7.3.5 QIAGEN (Exiqon) Recent Developments
7.4 QIAGEN (Exiqon)
7.4.1 QIAGEN (Exiqon) Profile
7.4.2 QIAGEN (Exiqon) Main Business
7.4.3 QIAGEN (Exiqon) MicroRNA (miRNA) Products, Services and Solutions
7.4.4 QIAGEN (Exiqon) MicroRNA (miRNA) Revenue (US$ Million) & (2019-2024)
7.4.5 QIAGEN (Exiqon) Recent Developments
7.5 NanoString Technologies, Inc.
7.5.1 NanoString Technologies, Inc. Profile
7.5.2 NanoString Technologies, Inc. Main Business
7.5.3 NanoString Technologies, Inc. MicroRNA (miRNA) Products, Services and Solutions
7.5.4 NanoString Technologies, Inc. MicroRNA (miRNA) Revenue (US$ Million) & (2019-2024)
7.5.5 NanoString Technologies, Inc. Recent Developments
7.6 Dharmacon (Horizon Discovery Group)
7.6.1 Dharmacon (Horizon Discovery Group) Profile
7.6.2 Dharmacon (Horizon Discovery Group) Main Business
7.6.3 Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Products, Services and Solutions
7.6.4 Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Revenue (US$ Million) & (2019-2024)
7.6.5 Dharmacon (Horizon Discovery Group) Recent Developments
7.7 Synlogic
7.7.1 Synlogic Profile
7.7.2 Synlogic Main Business
7.7.3 Synlogic MicroRNA (miRNA) Products, Services and Solutions
7.7.4 Synlogic MicroRNA (miRNA) Revenue (US$ Million) & (2019-2024)
7.7.5 Synlogic Recent Developments
7.8 GeneCopoeia, Inc.
7.8.1 GeneCopoeia, Inc. Profile
7.8.2 GeneCopoeia, Inc. Main Business
7.8.3 GeneCopoeia, Inc. MicroRNA (miRNA) Products, Services and Solutions
7.8.4 GeneCopoeia, Inc. MicroRNA (miRNA) Revenue (US$ Million) & (2019-2024)
7.8.5 GeneCopoeia, Inc. Recent Developments
7.9 New England Biolabs
7.9.1 New England Biolabs Profile
7.9.2 New England Biolabs Main Business
7.9.3 New England Biolabs MicroRNA (miRNA) Products, Services and Solutions
7.9.4 New England Biolabs MicroRNA (miRNA) Revenue (US$ Million) & (2019-2024)
7.9.5 New England Biolabs Recent Developments
7.10 Quantabio
7.10.1 Quantabio Profile
7.10.2 Quantabio Main Business
7.10.3 Quantabio MicroRNA (miRNA) Products, Services and Solutions
7.10.4 Quantabio MicroRNA (miRNA) Revenue (US$ Million) & (2019-2024)
7.10.5 Quantabio Recent Developments
7.11 NanoString Technologies, Inc.
7.11.1 NanoString Technologies, Inc. Profile
7.11.2 NanoString Technologies, Inc. Main Business
7.11.3 NanoString Technologies, Inc. MicroRNA (miRNA) Products, Services and Solutions
7.11.4 NanoString Technologies, Inc. MicroRNA (miRNA) Revenue (US$ Million) & (2019-2024)
7.11.5 NanoString Technologies, Inc. Recent Developments
7.12 BioGenex
7.12.1 BioGenex Profile
7.12.2 BioGenex Main Business
7.12.3 BioGenex MicroRNA (miRNA) Products, Services and Solutions
7.12.4 BioGenex MicroRNA (miRNA) Revenue (US$ Million) & (2019-2024)
7.12.5 BioGenex Recent Developments
7.13 SeqMatic LLC
7.13.1 SeqMatic LLC Profile
7.13.2 SeqMatic LLC Main Business
7.13.3 SeqMatic LLC MicroRNA (miRNA) Products, Services and Solutions
7.13.4 SeqMatic LLC MicroRNA (miRNA) Revenue (US$ Million) & (2019-2024)
7.13.5 SeqMatic LLC Recent Developments
8 Industry Chain Analysis
8.1 MicroRNA (miRNA) Industrial Chain
8.2 MicroRNA (miRNA) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 MicroRNA (miRNA) Sales Model
8.5.2 Sales Channel
8.5.3 MicroRNA (miRNA) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. MicroRNA (miRNA) Market Trends
    Table 2. MicroRNA (miRNA) Market Drivers & Opportunity
    Table 3. MicroRNA (miRNA) Market Challenges
    Table 4. MicroRNA (miRNA) Market Restraints
    Table 5. Global MicroRNA (miRNA) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global MicroRNA (miRNA) Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies MicroRNA (miRNA) Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies MicroRNA (miRNA) Product Type
    Table 9. Key Companies Time to Begin Mass Production of MicroRNA (miRNA)
    Table 10. Global MicroRNA (miRNA) Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MicroRNA (miRNA) as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global MicroRNA (miRNA) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global MicroRNA (miRNA) Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global MicroRNA (miRNA) Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global MicroRNA (miRNA) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global MicroRNA (miRNA) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global MicroRNA (miRNA) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global MicroRNA (miRNA) Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global MicroRNA (miRNA) Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global MicroRNA (miRNA) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global MicroRNA (miRNA) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global MicroRNA (miRNA) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global MicroRNA (miRNA) Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global MicroRNA (miRNA) Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global MicroRNA (miRNA) Sales Value by Region (2019-2024) & (%)
    Table 27. Global MicroRNA (miRNA) Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions MicroRNA (miRNA) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions MicroRNA (miRNA) Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions MicroRNA (miRNA) Sales Value, (2025-2030) & (US$ Million)
    Table 31. Thermofisher Scientific (Life Technologies) Basic Information List
    Table 32. Thermofisher Scientific (Life Technologies) Description and Business Overview
    Table 33. Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Products, Services and Solutions
    Table 34. Revenue (US$ Million) in MicroRNA (miRNA) Business of Thermofisher Scientific (Life Technologies) (2019-2024)
    Table 35. Thermofisher Scientific (Life Technologies) Recent Developments
    Table 36. Agilent Technologies Basic Information List
    Table 37. Agilent Technologies Description and Business Overview
    Table 38. Agilent Technologies MicroRNA (miRNA) Products, Services and Solutions
    Table 39. Revenue (US$ Million) in MicroRNA (miRNA) Business of Agilent Technologies (2019-2024)
    Table 40. Agilent Technologies Recent Developments
    Table 41. Merck KGaA Basic Information List
    Table 42. Merck KGaA Description and Business Overview
    Table 43. Merck KGaA MicroRNA (miRNA) Products, Services and Solutions
    Table 44. Revenue (US$ Million) in MicroRNA (miRNA) Business of Merck KGaA (2019-2024)
    Table 45. Merck KGaA Recent Developments
    Table 46. QIAGEN (Exiqon) Basic Information List
    Table 47. QIAGEN (Exiqon) Description and Business Overview
    Table 48. QIAGEN (Exiqon) MicroRNA (miRNA) Products, Services and Solutions
    Table 49. Revenue (US$ Million) in MicroRNA (miRNA) Business of QIAGEN (Exiqon) (2019-2024)
    Table 50. QIAGEN (Exiqon) Recent Developments
    Table 51. NanoString Technologies, Inc. Basic Information List
    Table 52. NanoString Technologies, Inc. Description and Business Overview
    Table 53. NanoString Technologies, Inc. MicroRNA (miRNA) Products, Services and Solutions
    Table 54. Revenue (US$ Million) in MicroRNA (miRNA) Business of NanoString Technologies, Inc. (2019-2024)
    Table 55. NanoString Technologies, Inc. Recent Developments
    Table 56. Dharmacon (Horizon Discovery Group) Basic Information List
    Table 57. Dharmacon (Horizon Discovery Group) Description and Business Overview
    Table 58. Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Products, Services and Solutions
    Table 59. Revenue (US$ Million) in MicroRNA (miRNA) Business of Dharmacon (Horizon Discovery Group) (2019-2024)
    Table 60. Dharmacon (Horizon Discovery Group) Recent Developments
    Table 61. Synlogic Basic Information List
    Table 62. Synlogic Description and Business Overview
    Table 63. Synlogic MicroRNA (miRNA) Products, Services and Solutions
    Table 64. Revenue (US$ Million) in MicroRNA (miRNA) Business of Synlogic (2019-2024)
    Table 65. Synlogic Recent Developments
    Table 66. GeneCopoeia, Inc. Basic Information List
    Table 67. GeneCopoeia, Inc. Description and Business Overview
    Table 68. GeneCopoeia, Inc. MicroRNA (miRNA) Products, Services and Solutions
    Table 69. Revenue (US$ Million) in MicroRNA (miRNA) Business of GeneCopoeia, Inc. (2019-2024)
    Table 70. GeneCopoeia, Inc. Recent Developments
    Table 71. New England Biolabs Basic Information List
    Table 72. New England Biolabs Description and Business Overview
    Table 73. New England Biolabs MicroRNA (miRNA) Products, Services and Solutions
    Table 74. Revenue (US$ Million) in MicroRNA (miRNA) Business of New England Biolabs (2019-2024)
    Table 75. New England Biolabs Recent Developments
    Table 76. Quantabio Basic Information List
    Table 77. Quantabio Description and Business Overview
    Table 78. Quantabio MicroRNA (miRNA) Products, Services and Solutions
    Table 79. Revenue (US$ Million) in MicroRNA (miRNA) Business of Quantabio (2019-2024)
    Table 80. Quantabio Recent Developments
    Table 81. NanoString Technologies, Inc. Basic Information List
    Table 82. NanoString Technologies, Inc. Description and Business Overview
    Table 83. NanoString Technologies, Inc. MicroRNA (miRNA) Products, Services and Solutions
    Table 84. Revenue (US$ Million) in MicroRNA (miRNA) Business of NanoString Technologies, Inc. (2019-2024)
    Table 85. NanoString Technologies, Inc. Recent Developments
    Table 86. BioGenex Basic Information List
    Table 87. BioGenex Description and Business Overview
    Table 88. BioGenex MicroRNA (miRNA) Products, Services and Solutions
    Table 89. Revenue (US$ Million) in MicroRNA (miRNA) Business of BioGenex (2019-2024)
    Table 90. BioGenex Recent Developments
    Table 91. SeqMatic LLC Basic Information List
    Table 92. SeqMatic LLC Description and Business Overview
    Table 93. SeqMatic LLC MicroRNA (miRNA) Products, Services and Solutions
    Table 94. Revenue (US$ Million) in MicroRNA (miRNA) Business of SeqMatic LLC (2019-2024)
    Table 95. SeqMatic LLC Recent Developments
    Table 96. Key Raw Materials Lists
    Table 97. Raw Materials Key Suppliers Lists
    Table 98. MicroRNA (miRNA) Downstream Customers
    Table 99. MicroRNA (miRNA) Distributors List
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
    Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. MicroRNA (miRNA) Product Picture
    Figure 2. Global MicroRNA (miRNA) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global MicroRNA (miRNA) Sales Value (2019-2030) & (US$ Million)
    Figure 4. MicroRNA (miRNA) Report Years Considered
    Figure 5. Global MicroRNA (miRNA) Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by MicroRNA (miRNA) Revenue in 2023
    Figure 7. MicroRNA (miRNA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Sample collection Picture
    Figure 9. miRNA cDNA Synthesis Picture
    Figure 10. Profiling & Purification Picture
    Figure 11. Detection Picture
    Figure 12. Functional Studies Picture
    Figure 13. Global MicroRNA (miRNA) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global MicroRNA (miRNA) Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Cancer
    Figure 16. Product Picture of Infectious Diseases
    Figure 17. Product Picture of Immunological Disorder
    Figure 18. Product Picture of Cardiovascular Disease
    Figure 19. Product Picture of Neurological Disease
    Figure 20. Product Picture of Others
    Figure 21. Global MicroRNA (miRNA) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global MicroRNA (miRNA) Sales Value Market Share by Application, 2023 & 2030
    Figure 23. North America MicroRNA (miRNA) Sales Value (2019-2030) & (US$ Million)
    Figure 24. North America MicroRNA (miRNA) Sales Value by Country (%), 2023 VS 2030
    Figure 25. Europe MicroRNA (miRNA) Sales Value (2019-2030) & (US$ Million)
    Figure 26. Europe MicroRNA (miRNA) Sales Value by Country (%), 2023 VS 2030
    Figure 27. Asia Pacific MicroRNA (miRNA) Sales Value (2019-2030) & (US$ Million)
    Figure 28. Asia Pacific MicroRNA (miRNA) Sales Value by Country (%), 2023 VS 2030
    Figure 29. South America MicroRNA (miRNA) Sales Value (2019-2030) & (US$ Million)
    Figure 30. South America MicroRNA (miRNA) Sales Value by Country (%), 2023 VS 2030
    Figure 31. Middle East & Africa MicroRNA (miRNA) Sales Value (2019-2030) & (US$ Million)
    Figure 32. Middle East & Africa MicroRNA (miRNA) Sales Value by Country (%), 2023 VS 2030
    Figure 33. Key Countries/Regions MicroRNA (miRNA) Sales Value (%), (2019-2030)
    Figure 34. United States MicroRNA (miRNA) Sales Value, (2019-2030) & (US$ Million)
    Figure 35. United States MicroRNA (miRNA) Sales Value by Type (%), 2023 VS 2030
    Figure 36. United States MicroRNA (miRNA) Sales Value by Application (%), 2023 VS 2030
    Figure 37. Europe MicroRNA (miRNA) Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Europe MicroRNA (miRNA) Sales Value by Type (%), 2023 VS 2030
    Figure 39. Europe MicroRNA (miRNA) Sales Value by Application (%), 2023 VS 2030
    Figure 40. China MicroRNA (miRNA) Sales Value, (2019-2030) & (US$ Million)
    Figure 41. China MicroRNA (miRNA) Sales Value by Type (%), 2023 VS 2030
    Figure 42. China MicroRNA (miRNA) Sales Value by Application (%), 2023 VS 2030
    Figure 43. Japan MicroRNA (miRNA) Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Japan MicroRNA (miRNA) Sales Value by Type (%), 2023 VS 2030
    Figure 45. Japan MicroRNA (miRNA) Sales Value by Application (%), 2023 VS 2030
    Figure 46. South Korea MicroRNA (miRNA) Sales Value, (2019-2030) & (US$ Million)
    Figure 47. South Korea MicroRNA (miRNA) Sales Value by Type (%), 2023 VS 2030
    Figure 48. South Korea MicroRNA (miRNA) Sales Value by Application (%), 2023 VS 2030
    Figure 49. Southeast Asia MicroRNA (miRNA) Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Southeast Asia MicroRNA (miRNA) Sales Value by Type (%), 2023 VS 2030
    Figure 51. Southeast Asia MicroRNA (miRNA) Sales Value by Application (%), 2023 VS 2030
    Figure 52. India MicroRNA (miRNA) Sales Value, (2019-2030) & (US$ Million)
    Figure 53. India MicroRNA (miRNA) Sales Value by Type (%), 2023 VS 2030
    Figure 54. India MicroRNA (miRNA) Sales Value by Application (%), 2023 VS 2030
    Figure 55. MicroRNA (miRNA) Industrial Chain
    Figure 56. MicroRNA (miRNA) Manufacturing Cost Structure
    Figure 57. Channels of Distribution (Direct Sales, and Distribution)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Medical Silicone Anatomy Models Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-31W18780
Fri Jan 31 00:00:00 UTC 2025

Add to Cart

Global Silicone Anatomy Models Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15X18988
Fri Jan 31 00:00:00 UTC 2025

Add to Cart

Global Computer-Assisted Protein Expression Design (CAPE) Platform Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29K18604
Fri Jan 31 00:00:00 UTC 2025

Add to Cart

Global Intracortical Brain-Computer Interfaces Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q19071
Fri Jan 24 00:00:00 UTC 2025

Add to Cart